Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BIBT 1011 - Healthy
    Clinical Study Number 1193.1
    Study Indication Healthy
    Product BIBT 1011
    Generic Name BIBT 1011
    Lab Code
    Clinical Phase I
    Study Title

    Safety, pharmacodynamics, and pharmacokinetics after single oral administration of 1, 5, 10, 30,100,200 and 400 mg BIBT 1011 BS as drinking solution in healthy subjects. An open, placebo­ controlled, randomised study, double blind at each dose level.

    Study Document
    Trial synopsis 1193.1 english